Rise and shine. Another busy day is on the way. And nothing like a long to-do list and a spot of sunshine to invigorate the endorphins. To cope, yes, we are brewing a cup or two of stimulation and, as always, invite you to join us. After all, everyone needs a little stimulation sometimes. So while you quaffe the contents of your cup, here are a few items of interest to help you along. Hope your day goes well and drop us a line if you hear anything interesting...
Merck KGgA Lung Cancer Drug Misses Trial Study Goal (Bloomberg News)
EMA Expects More New Drug Applications In 2013 (Reuters)
300 Medicis Workers Lose Jobs In Valeant Buy (Phoenix Business Journal)
Shire ADHD Drug Close To European Approval (Pharma Times)
S&P Predicts Quintiles Will Win More Market Share (Outsourcing Pharma)
WuXi And PRA Form Venture For China Trial (Pharma Business Review)
EDITOR'S NOTE: Please check this post for updates